View of Molecular docking studies FDA approved Quercetin inhibitory potential of ATP synthase F0F1 subunit beta from Streptococcus mutans

Return to Article Details Molecular docking studies FDA approved Quercetin inhibitory potential of ATP synthase F0F1 subunit beta from Streptococcus mutans Download Download PDF